1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985. 103:1796–1806.
2. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology. 1987. 94:761–774.
3. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse macular oedema: long-term visual results. Ophthalmology. 1991. 98:1594–1602.
4. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no.19. Arch Ophthalmol. 1995. 113:1144–1155.
5. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal Triamcinolone for Refractory Diabetic Macular Edema. Ophthalmology. 2002. 109:920–927.
6. Massin P, Audren F, Haouchine B, et al. Intravitreal Triamcinolone Acetonide for Diabetic Diffuse Macular Edema; Preliminary Results of a Prospective Controlled Trial. Ophthalmology. 2004. 111:218–225.
7. Karacorlu M, Ozdemir H, Karacorlu S, et al. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema. Eye. 2004. 19:382–386.
8. Ciardella AP, Klancnik J, Schiff W, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol. 2004. 88:1131–1136.
9. Jonas JB, Akkoyun I, Kreissig I, et al. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. Br J Ophthalmol. 2005. 89:321–326.
10. Jonas JB, Degenring RF, Kreissig I, et al. Intraocular Pressure Elevation after Intravitreal Triamcinolone Acetonide Injection. Ophthalmology. 2005. 112:593–598.
11. Smithen LM, Ober MD, Maranan L, et al. Intravitreal Triamcinolone Acetonide and Intraocular Pressure. Am J Ophthalmol. 2004. 138:740–743.
12. Park HY, Yi K, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol. 2005. 19:122–127.
13. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute Endophthalmitis Following Intravitreal Triamcinolone Acetonide Injection. Am J Ophthalmol. 2003. 136:791–796.
14. Ohguro N, Okada AA, Tano Y. Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2004. 242:444–445.
15. Bakri SJ, Kaiser PK. Posterior Subtenon Triamcinolone Acetonide for Refractory Diabetic Macular Edema. Am J Ophthalmol. 2005. 139:290–294.
16. Freeman WR, Green RL, Smith RE. Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol. 1987. 130:281–288.
17. Geroski DH, Edelhauser HF. Transscleral drug delivery for posterior segment disease. Adv Drug Deliv Rev. 2001. 52:37–48.
18. Weijtens O, van der Sluijs FA, Schoemaker RC, et al. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997. 123:358–363.
19. Cardillo JA, Melo LA Jr, Costa RA, et al. Comparison of Intravitreal versus Posterior Sub-Tenon's Capsule Injection of Triamcinolone Acetonide for Diffuse Diabetic Macular Edema. Ophthalmology. 2005. 112:1557–1563.
20. Bonini-Filho MA, Jorge R, Barbosa JC, et al. Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial. Invest Ophthalmol Vis Sci. 2005. 46:3845–3849.